Our Disctinct Advantage
20-for-20
20 Years Collaborating with other CROs
We’re a flexible & nimble trial partner
… Always a good match
20 Year Focus on Matching Needs of all Stakeholders
Reverse Feasibility Program™
… Benefits the Whole
20 Years of Surpassing the North American Industry Average
50% faster start-up
… for Every Single Trial
20 Years of Oncology Team Member Expertise
CRAs with oncology experience and privileged Site relationships
… Every One of Them
20 Years of Oncology Trial Management
Phase 1-3 performance numbers that speak louder than words
… We ‘Walk Our Talk’
20 Years of Respect & Value for our team
Satisfied, dedicated, loyal engaged employees
… Working for Your Trial Success
20 Years of Operations Excellence
Seamless operational communications – no silos, no internal bottlenecks
… Best in Our Niche
20 Years Ensuring Site Satisfaction
Pioneers of the patient-centric model in Canada
… Decades Ahead of the Competition
20 Years of Regulatory Submissions through Canadian Authorities
Keeping ahead of the changing landscape
… Timely & Effective
20 Years Solid Patient Recruitment Results
Quick start-up and high patient recruitment
… Contributes to Your Trials Overall Success
20 Years of Satisfied Sponsor Referrals
We’re proud of our repeat business
… Because we Surpass Expectations
20 Years of Steady, Dedicated Executive Leadership
Co-founders are passionate and involved
… Your Trials Matters
20 Years Managing Risk & Solving Problems
We’re diligent and trained to think outside-the-box
… Put Our Know-How to Work for Your Trial
20 Years of Growth
Due to dedication and excellence in the Canadian oncology research niche
… Distinct & Not to be Overlooked
20 Years Protecting Patient Security & Well Being
At the very heart of why we do what we do
… to Better Serve You
20 Years of Meaningful Contributions
… a Track Record We’re Proud of
Our Mission
We are a Canadian oncology CRO with a singular focus on oncology. We play a vital role in improving the speed and efficiency of oncology clinical research through a deep understanding of the needs of sponsors, investigators and patients.
Our mission is to improve site selection and patient recruitment, and speed up clinical trials by attracting cutting-edge oncology compounds and clinical trials to Canada. The Reverse Feasibility Program is designed to connect small and mid-sized biopharma companies with a network of highly motivated investigators and their patients.
We believe that the rise of targeted therapies and personalized medicine should not increase operational complexity or compromise the efficiency of clinical trials.
Our Story
Scimega was founded to meet the industry’s need for superior clinical trial services in the complex field of oncology research. In 1997, we were trail blazers, and most sponsors didn’t understand the importance of our unique business model. Since then many have come to value our expertise.
In 2008, we introduced the Reverse Feasibility Program – a collaborative approach that connects biotech sponsors with investigators to meet the needs of cancer patients, and the scientific interests of investigators while allowing sponsors to meet their timelines and make quicker go/no-go drug development decisions.
With 20 years of dedicated oncology experience under our belts, our service offering is now finely tuned at a time when our clients need us most.
Our Leadership
We are passionate advocates of the clinical oncology research community and take great pride in our team’s ongoing success in helping sponsors enhance the speed, accuracy and overall performance of their early phase oncology clinical trials.
We are also proud of the vital role we play in helping to build and maintain strong relationships between sponsors and investigative sites, in pursuit of cutting-edge clinical research that serves to enhance the quality of life of people living with cancer.
Denise Deakin
President & Co-Founder
Andree Marceau
General Manager & Co-Founder
Julie Martin, MSc, MBA
Director, Clinical Operations
Catherine Ménard, MSc
Director, Quality and Human Resources
Geneviève Piché
Director, Finance